Hema Biologics
KY - LouisvilleBiotechnology
Focus: Hema Biologics is a newly-founded (2024) biotechnology company headquartered in Louisville, KY focused on bleeding disorder treatments with a neurology therapeutic focus. The company is publicly staged but remains early-stage with minimal disclosed operations.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
9
Should You Work at Hema Biologics?
AI assessmentHema Biologics represents a high-risk, high-potential-reward opportunity for early-stage biotech entrepreneurs, but material absence of pipeline, financials, and hiring velocity makes it unsuitable for risk-averse professionals seeking stability or clear career progression.
Why Work Here
- Join a newly-public biotech focused on an underserved bleeding disorders market valued at $2.59B+ with recent FDA approvals in immune-cell therapies setting positive regulatory precedent
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Hema Biologics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.